177 related articles for article (PubMed ID: 37726305)
21. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantification of opiorphin in human saliva.
Brkljačić L; Sabalić M; Salarić I; Jerić I; Alajbeg I; Nemet I
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(32):3920-6. PubMed ID: 22119435
[TBL] [Abstract][Full Text] [Related]
22. Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways.
Javelot H; Messaoudi M; Garnier S; Rougeot C
J Physiol Pharmacol; 2010 Jun; 61(3):355-62. PubMed ID: 20610867
[TBL] [Abstract][Full Text] [Related]
23. Opiorphin causes a panicolytic-like effect in rat panic models mediated by μ-opioid receptors in the dorsal periaqueductal gray.
Maraschin JC; Rangel MP; Bonfim AJ; Kitayama M; Graeff FG; Zangrossi H; Audi EA
Neuropharmacology; 2016 Feb; 101():264-70. PubMed ID: 26363194
[TBL] [Abstract][Full Text] [Related]
24. Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways.
Wisner A; Dufour E; Messaoudi M; Nejdi A; Marcel A; Ungeheuer MN; Rougeot C
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17979-84. PubMed ID: 17101991
[TBL] [Abstract][Full Text] [Related]
25. Transfer of opiorphin through a blood-brain barrier culture model.
Bocsik A; Darula Z; Tóth G; Deli MA; Wollemann M
Arch Med Res; 2015 Aug; 46(6):502-6. PubMed ID: 26143971
[TBL] [Abstract][Full Text] [Related]
26. Xerostomia and salivary flow in patients with orofacial pain compared with controls.
da Silva LA; Teixeira MJ; de Siqueira JT; de Siqueira SR
Arch Oral Biol; 2011 Oct; 56(10):1142-7. PubMed ID: 21612767
[TBL] [Abstract][Full Text] [Related]
27. Association between medication-induced xerostomia and orofacial pain: a systematic review.
Kohli D; Madhu N; Korczeniewska OA; Eliav T; Arany S
Quintessence Int; 2023 Sep; 54(8):658-670. PubMed ID: 37305957
[TBL] [Abstract][Full Text] [Related]
28. Effects and underlying mechanisms of human opiorphin on colonic motility and nociception in mice.
Tian XZ; Chen J; Xiong W; He T; Chen Q
Peptides; 2009 Jul; 30(7):1348-54. PubMed ID: 19442408
[TBL] [Abstract][Full Text] [Related]
29. Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice.
Popik P; Kamysz E; Kreczko J; Wróbel M
Behav Brain Res; 2010 Nov; 213(1):88-93. PubMed ID: 20438769
[TBL] [Abstract][Full Text] [Related]
30. Effects of synthetic analogues of human opiorphin on rat brain opioid receptors.
Benyhe Z; Toth G; Wollemann M; Borsodi A; Helyes Z; Rougeot C; Benyhe S
J Physiol Pharmacol; 2014 Aug; 65(4):525-30. PubMed ID: 25179084
[TBL] [Abstract][Full Text] [Related]
31. B2-kinin receptors in the dorsal periaqueductal gray are implicated in the panicolytic-like effect of opiorphin.
Sestile CC; Maraschin JC; Rangel MP; Santana RG; Zangrossi H; Graeff FG; Audi EA
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):493-498. PubMed ID: 28797641
[TBL] [Abstract][Full Text] [Related]
32. Full-mouth treatment modalities (within 24 hours) for chronic periodontitis in adults.
Eberhard J; Jepsen S; Jervøe-Storm PM; Needleman I; Worthington HV
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD004622. PubMed ID: 25884249
[TBL] [Abstract][Full Text] [Related]
33. Effects of the adjunctive treatment of antidepressants with opiorphin on a panic-like defensive response in rats.
Maraschin JC; Sestile CC; Yabiku CT; Roncon CM; de Souza Fiaes GC; Graeff FG; Audi EA; Zangrossi H
Behav Brain Res; 2020 Jan; 378():112263. PubMed ID: 31568834
[TBL] [Abstract][Full Text] [Related]
34. Salivary Endocannabinoid Profiles in Chronic Orofacial Pain and Headache Disorders: An Observational Study Using a Novel Tool for Diagnosis and Management.
Heiliczer S; Wilensky A; Gaver T; Georgiev O; Hamad S; Nemirovski A; Hadar R; Sharav Y; Aframian DJ; Tam J; Haviv Y
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361803
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum.
Kamysz E; Sałaga M; Sobczak M; Kamysz W; Fichna J
J Pept Sci; 2013 Mar; 19(3):166-72. PubMed ID: 23381913
[TBL] [Abstract][Full Text] [Related]
36. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
Elmahgoub F
Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
[TBL] [Abstract][Full Text] [Related]
37. Orofacial Pain Management: An Overview of the Potential Benefits of Palmitoylethanolamide and Other Natural Agents.
Santonocito S; Donzella M; Venezia P; Nicolosi G; Mauceri R; Isola G
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111679
[TBL] [Abstract][Full Text] [Related]
38. Does Articaine Provide an Advantage over Lidocaine in Patients with Symptomatic Irreversible Pulpitis? A Systematic Review and Meta-analysis.
Kung J; McDonagh M; Sedgley CM
J Endod; 2015 Nov; 41(11):1784-94. PubMed ID: 26293174
[TBL] [Abstract][Full Text] [Related]
39. Association between primary headaches and temporomandibular disorders: A systematic review and meta-analysis.
Réus JC; Polmann H; Souza BDM; Flores-Mir C; Gonçalves DAG; de Queiroz LP; Okeson J; De Luca Canto G
J Am Dent Assoc; 2022 Feb; 153(2):120-131.e6. PubMed ID: 34649707
[TBL] [Abstract][Full Text] [Related]
40. Salivary Biomarkers (Opiorphin, Cortisol, Amylase, and IgA) Related to Age, Sex, and Stress Perception in a Prospective Cohort of Healthy Schoolchildren.
Krahel A; Paszynska E; Otulakowska-Skrzynska J; Rzatowski S; Hernik A; Slopien A; Hanć T; Szczesniewska P; Bryl E; Boucher Y; Tyszkiewicz-Nwafor M; Gawriolek M; Dmitrzak-Weglarz M
Mediators Inflamm; 2021; 2021():3639441. PubMed ID: 35110971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
